Nephros (NEPH) Non-Current Deffered Revenue (2011 - 2017)
Nephros (NEPH) recorded quarterly Non-Current Deffered Revenue of $208000.0 in Q4 2017, down 7.56% quarter-over-quarter from $225000.0 in Q3 2017, and down 25.18% on a YoY basis from $278000.0 in Q4 2016.
Nephros (NEPH) Non-Current Deffered Revenue (2011 - 2017) Analysis & Trends
Nephros' Non-Current Deffered Revenue history runs 7 years deep, the most recent figure standing at $208000.0 for Q4 2017.
- In Q4 2017, Non-Current Deffered Revenue fell 25.18% year-over-year to $208000.0; the TTM figure through Dec 2017 stood at $208000.0 (down 25.18% YoY), while the FY2017 annual figure was $208000.0, down 25.18% from the prior year.
- Non-Current Deffered Revenue was $208000.0 for Q4 2017 at Nephros, down from $225000.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $531000.0 in Q1 2013 to a low of $176000.0 in Q3 2013.
- Historically, Non-Current Deffered Revenue has averaged $333833.3 across 5 years, with a median of $338500.0 in 2015.
- The sharpest annual moves came in 2013 and 2014: Non-Current Deffered Revenue plunged 80.02% in 2013, then surged 146.59% in 2014.
- A 5-year view of Non-Current Deffered Revenue shows it stood at $176000.0 in 2013, then soared by 136.93% to $417000.0 in 2014, then dropped by 16.79% to $347000.0 in 2015, then declined by 19.88% to $278000.0 in 2016, then declined by 25.18% to $208000.0 in 2017.
- The last three Non-Current Deffered Revenue figures came in at $208000.0 (Q4 2017), $225000.0 (Q3 2017), and $243000.0 (Q2 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 163.15 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 11.80 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 208.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 208,000.00 |
| Sep 30, 2017 | 225,000.00 |
| Jun 30, 2017 | 243,000.00 |
| Mar 31, 2017 | 261,000.00 |
| Dec 31, 2016 | 278,000.00 |
| Sep 30, 2016 | 295,000.00 |
| Jun 30, 2016 | 313,000.00 |
| Mar 31, 2016 | 330,000.00 |
| Dec 31, 2015 | 347,000.00 |
| Sep 30, 2015 | 365,000.00 |
| Jun 30, 2015 | 382,000.00 |
| Mar 31, 2015 | 400,000.00 |
| Dec 31, 2014 | 417,000.00 |
| Sep 30, 2014 | 434,000.00 |
| Jun 30, 2014 | 452,000.00 |
| Sep 30, 2013 | 176,000.00 |
| Jun 30, 2013 | 352,000.00 |
| Mar 31, 2013 | 531,000.00 |
| Dec 31, 2012 | 707,000.00 |
| Sep 30, 2012 | 881,000.00 |